3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Biphenotypic, Acute
3
Hodgkin Disease
3
Neutropenia
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Monocytic, Acute
2
Triple Negative Breast Neoplasms
1
Thoracic Neoplasms
1
Teratoma
1
Solid Tumors
1
Sarcoma, Myeloid
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Patients With Nonmyeloid Malignancies Receiving Antineoplastic Therapy Based on Chemotherapy Regimens at Moderate to High Febrile Neutropenia (FN) Risk
1
Osteosarcoma
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Lymphoma, T-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, AIDS-Related
1
Leukemia, Plasma Cell
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Accelerated Phase
1
Interventions
asciminib
1
Etoposide
1
Cisplatin
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Malignant Solid Tumors
×
pegylated granulocyte colony-stimulating factor
×
1 year
×
Clear all
No trials found.